Feb 24, 2021 / 06:40PM GMT
Ami Fadia - SVB Leerink LLC, Research Division - MD of Biopharma & Generics and Senior Analyst
Good afternoon, everyone. Thank you for joining the next session with Jazz Pharmaceuticals. As a reminder, I'm Ami Fadia. I cover biopharma and generic here at SVB Leerink. And as we go through some of the Q&A, if you'd like me to ask any question on your behalf, feel free to send it over to me in the dashboard.
I have a pleasure of hosting Bruce Cozadd, who is the Chairman and CEO of Jazz. And along with him, Justin Gover, who's CEO of GW Pharma. Thank you both for joining us today. Also from Jazz's side, I've got Robert Iannone, who's the Head of Research and Development; as well as Kim Sablich, who's the Executive Vice President and General Manager of North America.
Questions and Answers:
Ami Fadia - SVB Leerink LLC, Research Division - MD of Biopharma & Generics and Senior AnalystWith that, I'd like to thank everybody for joining.
And Bruce, if you could kick us off with some initial comments. You've had a few busy months
Trustpilot
